Profusa, Inc. (PFSA)
About Profusa, Inc.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $100.0K
- Net income
- -$35.8M
- Total assets
- $3.8M
- Market cap
- $1.3M
Source: SEC EDGAR · updated Jun 8, 2026
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $27.7M
- Operating income
- -$27.7M
- Income tax
- -$5.5M
- Net income
- -$35.8M
- EPS (basic)
- $-107.01
- EPS (diluted)
- $-107.01
Balance sheet
- Total assets
- $3.8M
- Current assets
- $3.8M
- Total liabilities
- $30.4M
- Current liabilities
- $22.3M
- Shareholders’ equity
- -$26.7M
Cash flow
- Operating cash flow
- -$16.2M
- Investing cash flow
- -$2.0M
- Financing cash flow
- $19.8M
- Net cash flow
- $1.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.3M
- EPS (diluted)
- $-107.01
- Shares outstanding
- 731.2K
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 14, 2025
Profusa, Inc. (PFSA) Stock Price
- Reported a net loss of $35.8M in FY2024.
- Trading 100% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Profusa, Inc..
Write a review
News about Profusa, Inc.
News & sentiment via Polygon.io
Profusa, Inc.: frequently asked questions
Is Profusa, Inc. an American company?
Profusa, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Profusa, Inc. headquartered?
Profusa, Inc. is headquartered in New York, New York, United States.
Is Profusa, Inc. publicly traded?
Yes — Profusa, Inc. is a publicly traded company. Its stock trades under the ticker symbol PFSA on the NASDAQ.
What does Profusa, Inc. do?
Profusa, Inc. is an American Medical Devices company in the Health & Beauty sector.
